维普期刊资源整合服务平台（V6.5）

126篇 您的检索式：作者名="Del Poeta"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab 显示文摘	Stasi R Cooper N Del Poeta G	2008	Blood2008，112，4：	1
2	Comparison of in vitro activities of camptothecin and nitidine derivatives against fungal and cancer cells 显示文摘	Del Poeta M Chen SF Von Hoff D	1999	Antimicrob Agents Chemother1999，43，12：	1
3	CD7 expression in acute myeloid leukemia显示文摘	Del Poeta G Stasi R Venditti A	1995	Leuk Lymphoma1995，17，12：	1
4	Prognostic value of cell mark er analysis in de novo acute myeloid leukemia显示文摘	Stasi R Vendrrn A	1994	Leukemia1994，8，：	1
5	Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B celldepleting therapy with rituximab显示文摘	Stasi R Cooper N Del Poeta G	2008	Blood2008，112，4：	1
6	Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia显示文摘	Buccisano F Del Poeta G	2000	Blood2000，96，12：	1
7	Response to B-cell de- pleting therapy with rituximab reverts the abnormalities of T- cell subsets in patients with idiopathic thrombocytopenic pur- pura显示文摘	Stasi R Del Poeta G Stipa E	2007	Blood2007，110，8：	1
8	Response to B-cell-depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura 显示文摘	Stasi R Del Poeta G Stipa E	2007	Blood2007，110，8：	1
9	Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell depleting therapy with rituximab显示文摘	Stasi R Cooper N del Poeta G	2008	Blood2008，112，4：	1
10	Level of minimal residual disease after consolidation therapy pre- dicts outcome in acute myeloid leukemia 显示文摘	Venditti A Buccisano F Del Poeta G	2000	Blood2000，96，12：	1
11	Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-M0)显示文摘	Stasi R Del Poeta G Venditti A	1994	Blood1994，83，6：	1
12	CD7 positive acute myeloid leukemia显示文摘	Del Poeta G Stasi R Venditti A	1993	Blood1993，82，9：	1
13	Apoptosis and immaturity in acute myeloid leukemia 显示文摘	Del Principe MI Del Poeta G Venditti A	2005	Hematology2005，10，1：	1
14	Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab显示文摘	Stasi R Cooper N Del Poeta G	2008	Blood2008，112，：	1
15	Clinical signif- icance of CD38 expression in chronic lymphocytic leukemia显示文摘	Del Poeta G Maurillo L Venditti A	2001	Blood2001，98，9：	1
16	Comparison of In vitro activities of camptothetin and nitidine derivatives against fungal and cancer cells 显示文摘	Maurizio Del Poeta	1999	Antimicrob Agents Chemother1999，43，12：	1
17	显示文摘	Venditti A Del Poeta GD	1998	Am J Med Sci1998，315，4：	1
18	The addition of rituximab to fludarabine improves clinical out- come in untreated patients with ZAp-70-negative chronic lymphocytic leukemia 显示文摘	Del Poeta G Del Principe MI Consalvo MA	2005	Cancer2005，104，12：	1
19	Minimally differetiated acute myeloid leukemia(AML-M0): Comparison of 25 cases with other french-american-british subtypes显示文摘	Venditti A Del Poeta G Buccisano F	1997	Blood1997，89，2：	1
20	Minimally differentiated acute myeloid leukemia (AML-M0): comparison of 25 cases with other French-American-British subtypes 显示文摘	Venditti A Del Poeta G Buccisano F	1997	Blood1997，89，1：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示